Ligand Pharmaceuticals Inc (LGND)
R&D Expenses
$41.35M
TTM · Period ending: · USD
LGND R&D Expenses
Latest reported$41.35Mperiod ending
Latest reported$41.35Mperiod ending
LGND R&D Expenses ($0.00 → $41.35M)
Annual R&D Expenses
High-resolution chart · PNG
LGND r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 81,182,000 | |
| 21,425,000 | |
| 24,537,000 | |
| 36,082,000 | |
| 32,105,000 | |
| 40,503,000 | |
| 55,908,000 | |
| 27,863,000 | |
| 26,887,000 | |
| 21,221,000 | |
| 13,380,000 | |
| 12,122,000 | |
| 9,274,000 | |
| 10,790,000 | |
| 10,291,000 | |
| 22,067,000 | |
| 39,870,000 | |
| 30,770,000 | |
| 44,623,000 | |
| 41,926,000 | |
| 56,075,000 | |
| 65,204,000 | |
| 67,679,000 | |
| 58,807,000 | |
| 51,104,000 | |
| 51,287,000 | |
| 59,400,000 | |
| 70,700,000 | |
| 72,400,000 | |
| 59,500,000 | |
| 41,400,000 | |
| 0 |